Enoxaparin sodium GMP approved quality

The majority of the components present a4-enopyranose uronate structure at the non-reduced end and 15 %~25% of thecomponents have a 1, 6-anhydro structure at the reducing end of their chain;the average relative molecular mass is between 3800 and 5000 with acharacteristic value of about 4500; the degree of sulfatation is about 2 perdisaccharidic unit.

Enoxaparin Sodium  is indicatedfor the prophylaxis of vein thrombosis diseases (prevent intra-veinthrombosis), treatment of deep vein thrombosis, prophylaxis of thrombosis invitra circulation for blood dialysis, treatment of unstable angina andnon-Q-wave myocardial infarction when concurrently administered with aspirin.